Last edition
News about "Gilgamesh Pharmaceuticals to Expand Mental Health "
Global biopharmaceutical company AbbVie is reportedly in advanced talks to acquire Gilgamesh Pharmaceuticals in a deal valued at approximately USD 1 billion, according to people familiar with the matter. The acquisition would further AbbVie’s strategic expansion into the mental health treatment space.
Gilgamesh Pharmaceuticals To Expand Mental Health | 31/07/2025 | By Darshana | 165
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members